Ketamine Enrolling by Invitation Phase 1 Trials for Unipolar Depression / Bipolar I Disorder / Major Depressive Disorder (MDD) / Bipolar II Disorder Basic Science

IndicationsStatusPurposePhase
Enrolling by InvitationBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03156504The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.